Download Leukaemia Section t(20;21)(q13.2;q22.12) ZFP64/RUNX1 Atlas of Genetics and Cytogenetics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

X-inactivation wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Minimal genome wikipedia , lookup

Short interspersed nuclear elements (SINEs) wikipedia , lookup

History of genetic engineering wikipedia , lookup

Non-coding RNA wikipedia , lookup

Non-coding DNA wikipedia , lookup

Genome evolution wikipedia , lookup

Protein moonlighting wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Long non-coding RNA wikipedia , lookup

Gene expression programming wikipedia , lookup

Histone acetyltransferase wikipedia , lookup

Gene nomenclature wikipedia , lookup

Genome (book) wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

RNA-Seq wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Epigenetics in learning and memory wikipedia , lookup

Gene expression profiling wikipedia , lookup

Point mutation wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Microevolution wikipedia , lookup

Gene wikipedia , lookup

Transcription factor wikipedia , lookup

Designer baby wikipedia , lookup

Helitron (biology) wikipedia , lookup

Primary transcript wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Epigenetics of human development wikipedia , lookup

NEDD9 wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
INIST-CNRS
OPEN ACCESS JOURNAL
Leukaemia Section
Short Communication
t(20;21)(q13.2;q22.12) ZFP64/RUNX1
Nathalie Douet-Guilbert, Etienne De Braekeleer, Audrey Basinko, Marie-Josée Le Bris, Frédéric
Morel, Marc De Braekeleer
Cytogenetics Laboratory, Faculty of Medicine, University of Brest, France (NDG, ED, AB, MJL, FM, MD)
Published in Atlas Database: December 2012
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t2021q13q22ID1590.html
DOI: 10.4267/2042/49703
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2013 Atlas of Genetics and Cytogenetics in Oncology and Haematology
domain but remove the transcription activation domain
have a leukemogenic effect by acting as dominant
negative inhibitors of wild-type RUNX1 in
transcription activation (De Braekeleer et al., 2011).
Clinics and pathology
Disease
Chronic myelomonocytic leukemia (CMML)
Epidemiology
This is a rare chromosomal rearrangement, only
reported twice in myeloid hemopathies, without
molecular characterization but for the case reported by
Richkind et al. (2000) who showed rearrangement of
RUNX1 (Secker-Walker et al., 1995; Richkind et al.,
2000).
RHG banding showing chromosomes 20 and 21 and the
derivatives der(20) and der(21).
Cytogenetics morphological
Clinics
t(20;21)(q13.2;q22.12) identified by FISH in a clone
having a trisomy 8 (cryptic rearrangement).
A 91-year old woman seen for fever and thrombopenia.
Cytogenetics molecular
Cytogenetics
FISH showed that the breakpoint on 21q22 was located
in RUNX1. To confirm the position of the breakpoint
on chromosome 20, BACs located at 20q13 were used
as probes in FISH experiments. Analysis with RP11184L6 showed that one signal hybridized to the normal
chromosome 20, and the other splitted and hybridized
to both der(20) and der(21). Co-hybridization with the
RP11-184L6 clone and a RUNX1 probe (RP11-77G18)
showed two fusion signals. RP11-184L6 contains the
ZFP64 gene.
Note
The t(20;21)(q13.2;q22.12) involves the RUNX1 (alias
AML1) gene that acts as an activator or repressor of
target gene expression depending upon the large
number of transcription factors, coactivators and
corepressors that interact with it. RUNX1 functions as
an organizing protein that facilitates assembly of
transcriptional activation or repression complexes.
All the translocations that retain Runt homology
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(5)
341
t(20;21)(q13.2;q22.12) ZFP64/RUNX1
Douet-Guilbert N, et al.
FISH with BACs RP11-77G18 (spectrum green, located in 21q22.12 and containing RUNX1) and RP11-184L6 (spectrum orange, located
in 20q13.2 and containing ZFP64) showing co-hybridization of both derivative chromosomes.
At least 12 different RUNX1 mRNAs differing in their
types of 5' and 3' untranslated regions (UTRs) and their
coding regions are generated.
Protein
The RUNX1 protein contains a 'Runt homology
domain' as well as transcription activation and
inhibition domains.
It acts as an activator or repressor of target gene
expression depending upon the large number of
transcription factors, coactivators and corepressors that
interact with it.
RUNX1 functions as an organizing protein that
facilitates assembly of transcriptional activation or
repression complexes.
By recruitment of non-DNA binding proteins as
p300/CBP and histone acetyltransferase, it contributes
to the activation of transcription of target genes.
Upon recruitment of non-DNA binding repressors such
as mSin3A, Groucho/TLE and histone deacetylase, it
represses transcription of target genes.
Genes involved and proteins
RUNX1
Location
21q22.12
Note
RUNX1 belongs to a family of genes that share a 128
amino acid region of high sequence homology, known
as the 'Runt domain', first identified in the Drosophila
runt gene.
This 'Runt homology domain' is responsible for
heterodimerization with the core-binding factor-b
(CBF-b or PEBP2b) to form a transcription factor and
for DNA binding.
RUNX1 acts as a key regulator of hematopoiesis
through the regulation of various hematopoietic genes,
including growth factors (GM-CSF, MPO and IL-3),
surface receptors (TCRA, TCRB, M-CSF receptor and
FLT3), signaling molecules (CDKN1A, BLK and
BCL2) and transcription activators (STAT3 and MYB).
DNA/RNA
The RUNX1 gene spans 260 kb and consists of 12
exons with two distinct promoters.
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(5)
ZFP64
Location
20q13.2
342
t(20;21)(q13.2;q22.12) ZFP64/RUNX1
Douet-Guilbert N, et al.
Richkind K, Hromas R, Lytle C, Crenshaw D, Velasco J,
Roherty S, Srinivasiah J, Varella-Garcia M. Identification of two
new translocations that disrupt the AML1 gene. Cancer Genet
Cytogenet. 2000 Oct 15;122(2):141-3
DNA/RNA
The ZFP64 gene contains 6 exons spanning 41 kb.
Twelwe transcripts are known, of which 9 are protein
coding.
Protein
ZFP64 protein belongs to the krueppel C2H2-type zincfinger protein family and contains 9 C2H2-type zinc
fingers.
It may be involved in transcriptional regulation. It
interacts with the intracellular domain of Notch1, and
acts as a coactivator of the Notch intracellular domain
(Sakamoto et al., 2008).
Sakamoto K, Tamamura Y, Katsube K, Yamaguchi A. Zfp64
participates in Notch signaling and regulates differentiation in
mesenchymal cells. J Cell Sci. 2008 May 15;121(Pt 10):161323
De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Férec
C, De Braekeleer M. RUNX1 translocations and fusion genes
in malignant hemopathies. Future Oncol. 2011 Jan;7(1):77-91
This article should be referenced as such:
Douet-Guilbert N, De Braekeleer E, Basinko A, Le Bris MJ,
Morel F, De Braekeleer M. t(20;21)(q13.2;q22.12)
ZFP64/RUNX1. Atlas Genet Cytogenet Oncol Haematol. 2013;
17(5):341-343.
References
Secker-Walker LM, Mehta A, Bain B. Abnormalities of 3q21
and 3q26 in myeloid malignancy: a United Kingdom Cancer
Cytogenetic Group study. Br J Haematol. 1995 Oct;91(2):490501
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(5)
343
Related documents
Leukaemia Section t(8;21)(q23;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(8;21)(q23;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;21)(q34;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;21)(q34;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;21)(q21;q22)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(11;21)(q21;q22) Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Paper title - Health in Wales
Paper title - Health in Wales
Path Seminar_Amarni_Luke
Path Seminar_Amarni_Luke
Leukaemia Section t(1;21)(p22;q22) RUNX1/CLCA2  Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(p22;q22) RUNX1/CLCA2 Atlas of Genetics and Cytogenetics
Leukaemia Section dup(21q) amplified (RUNX1) Atlas of Genetics and Cytogenetics
Leukaemia Section dup(21q) amplified (RUNX1) Atlas of Genetics and Cytogenetics
RUNX1 Modulates TGF-β1-Induced Myofibroblast Differentiation in
RUNX1 Modulates TGF-β1-Induced Myofibroblast Differentiation in
ICM - IS MU
ICM - IS MU
- Haematopoietic Stem Cell Lab
- Haematopoietic Stem Cell Lab
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ATF1 (activating transcription factor 1) Atlas of Genetics and Cytogenetics
Gene Section ATF1 (activating transcription factor 1) Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section Familial platelet disorder with predisposition to
Cancer Prone Disease Section Familial platelet disorder with predisposition to
Runx1 modulates developmental, but not injury
Runx1 modulates developmental, but not injury
Functional features of RUNX1 mutants in acute
Functional features of RUNX1 mutants in acute